The first stop for professional medicines advice

Extended-release methylphenidate: A review of the pharmacokinetic profiles of available products

Hina Radia, Medicines Information Pharmacist, London and South East Regional Medicines InformationPublished
Topics: Mental health and illnessMethylphenidatePaediatrics

This review discusses current NICE recommendations for the use of methylphenidate for the treatment of ADHD and describes the pharmacokinetic differences between the currently available modified-release products available: Concerta XL, Delmosart XL, Equasym XL, Matoride XL, Medikinet XL, Ritalin XL, Xaggitin XL and Xenidate XL.

Attachments